Explorer les evidences

101 testsMean quarterly HBV tests were 101 ± 3 during July–September in Freetown, Sierra Leone.

Sierra Leonehépatite Bobservé July-Septemberpublié 2023Impact of COVID-19 on Hepatitis B Screening in Sierra Leone: Insights from a Community Phaeurope_pmcdocument de 8 observationsDOI 10.1101/2023.05.24.23290418

The highest incidence of Lassa fever in Sierra Leone was observed during the dry season.

Sierra Leonefièvre de Lassapublié 2014PLoS neglected tropical diseaseseurope_pmcdocument de 6 observations

28,1 %Among children and adolescents in Sierra Leone, Y181C/V/I was found in 28.1% (n = 18/64) of cases.

Sierra LeoneVIH/sidapublié 2021Geneseurope_pmcdocument de 21 observationsDOI 10.3390/genes12091314

6 aORRenal impairment was associated with hypertension among people living with HIV, with an adjusted odds ratio of 6.00.

Sierra Leonehypertension artérielle · renal impairmentpublié 2022Journal of clinical medicineeurope_pmcdocument de 9 observations

412 cells/mm³The median CD4 count among enrolled people with HIV in Freetown, Sierra Leone was 412 cells/mm³.

Sierra LeoneVIH/sidaobservé April to June 2022publié 2023Vaccineseurope_pmcdocument de 5 observationsDOI 10.3390/vaccines11111685

13,4 %The prevalence of smoking among adults in Freetown, Sierra Leone was 13.4%.

Sierra Leonesmokingobservé 2019–2021publié 2023Burden of cardiometabolic risk factors and preclinical target organ damage among adults ineurope_pmcdocument de 8 observationsDOI 10.1101/2023.02.20.23286145

75 %Antivirals were used in 75% of the articles on COVID-19 patients with sepsis or septic shock.

Sierra LeoneCOVID-19 · sepsis · septic shockpublié 2020Sepsis and septic shock in COVID-19: a scoping review of the research dataeurope_pmcdocument de 17 observationsDOI 10.21203/rs.3.rs-30474/v1

26,4 %Among 197 patients with chronic respiratory symptoms in an urban tertiary hospital in Sierra Leone, 52 (26.4%) were HIV positive.

Sierra LeoneVIH/sidaobservé November 2021 to July 2022publié 2023PLoS neglected tropical diseaseseurope_pmcdocument de 9 observations

59,5 %Among healthcare professionals in Sierra Leone surveyed from January to March 2022, 59.5% reported a preference for natural immunity regarding COVID-19 vaccines.

Sierra LeoneCOVID-19observé January to March 2022publié 2022Vaccineseurope_pmcdocument de 12 observations

The case fatality rate of ribavirin-treated patients presenting early in acute infection was lower than in untreated subjects.

Sierra Leonefièvre de Lassapublié 2014PLoS neglected tropical diseaseseurope_pmcdocument de 6 observations

5 000 adultsIn Sierra Leone, there are an estimated 5000 adults with allergic bronchopulmonary aspergillosis complicating asthma.

Sierra Leoneallergic bronchopulmonary aspergillosis · asthmepublié 2021Therapeutic advances in infectious diseaseeurope_pmcdocument de 9 observations

33 %Of the gram-negative bacteria, 33% were Carbapenem-resistant Pseudomonas aeruginosa.

Sierra LeoneCarbapenem-resistant Pseudomonas aeruginosapublié 2022Therapeutic advances in infectious diseaseeurope_pmcdocument de 6 observations

52,2 %Among 306 adult participants in Freetown, Sierra Leone, 52.2% had good HBV knowledge.

Sierra Leonehépatite Bpublié 2023Healthcare (Basel, Switzerland)europe_pmcdocument de 5 observationsDOI 10.3390/healthcare11020177